Objective: To summarize available literature containing data on the treatment of depression in palliative care patients.
Methods: A systematic review was conducted using extensive electronic databases and hand searches. All randomized controlled trials (RCTs) of interventions for depression in patients with advanced disease were eligible.
Results: Three RCTs assessed pharmacological treatments. Of these, two were placebo controlled and assessed mianserin and thioridazine. The third compared two antidepressants. There were no RCTs that specifically assessed psychotherapy for patients with depression.
Conclusion: There are too few adequate studies to draw clear conclusions about management of depression in this setting. The treatment of depression in patients with advanced disease must, for now, be informed by the larger body of evidence on effective treatments for depression in patients with either no physical illness or less severe medical conditions.
Payne S. Depression in palliative care patients: a literature review. Int J Palliat Nurs1998; 4: 184–191.
3.
McVey P. Literature review. Depression among the palliative care oncology population. Int J Palliat Nurs1998; 4: 86–93.
4.
Brugha TS. Depression in the terminally ill. Br J Hosp Med1993; 50: 175, 177–181.
5.
Billings JA, Block S. Depression. J Palliat Care1995; 11: 48–54.
6.
Swire N, George RJD. Depression in palliative care. In Robertson MM, Katona CLE eds. Depression and physical illness. Oxford: Wiley, 1997: 443–463.
7.
Bottomley A. Depression in cancer patients: a literature review. Eur J Cancer Care1998; 7: 181–191.
8.
Goldberg RJ. Management of depression in the patient with advanced cancer. J Am Med Assoc1981; 264: 373–376.
9.
Hotopf M, Chidgey J, Addington-Hall J, Ly KL. Depresion in advanced disease: a syatematic review. Part I. Prevelance and case finding. Palliant Med. 2002; 16: 81–97.
10.
Costa D, Mogos I, Toma T. Efficacy and safety of mianserin in the treatment of depression of woman with cancer. Acta Psychiatr Scand1985; 72(suppl 30): 85–92.
11.
Holland JC, Romano SJ, Heilgenstein JH, Tepner RG, Wilson MG. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psycho-Oncology1998; 7: 291–300.
12.
Johnston B. Relief of mixed anxiety– depression in terminal cancer patients: effect of thioridazine. NY State J Med1972; 72: 2315–2317.
13.
De Vries MJ, Schilder JN, Mulder CL, Vrancken AME, Remie ME, Garssen B. Phase II study of psychotherapeutic intervention in advanced cancer. Psycho-Oncology1997; 6: 129–137.
14.
Linn MW, Linn BS, Harris R. Effects of counseling for late stage cancer patients. Cancer1982; 49: 1048–1055.
Higginson IJ. Evidence based palliative care. Br Med J1999; 319: 462–463.
17.
Hotopf M, Hardy R, Lewis G. Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. Br J Psychiatry1997; 170: 120–127.
18.
Gill D, Hatcher S. A systematic review of the treatment of depression with antidepressant drugs in patients who also have a physical illness. J Psychosom Res1999; 47: 131–143.
19.
Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med1992; 326: 1250–1256.
20.
Lloyd-Williams M, Friedman T, Rudd N. A survey of antidepressant prescribing in the terminally ill. Palliat Med1999; 13: 243–248.
21.
Chiarillo RJ, Cole JO. The use of psychostimulants in general psychiatry. A reconsideration. Arch Gen Psychiatry1987; 44: 286–295.
22.
Hotopf M, Churchill R, Lewis G. The pragmatic randomized controlled trial in psychiatry. Br J Psychiatry1999; 175: 217–223.
23.
Chalmers I, Lindley R. Double standards on informed consent to treatment. In Doyle LS, Tobias JS eds. Informed consent in medical research. London: BMJ Publications, 2000: 266–275.
